Approval · Notice of Compliance 16576 · 2015
ENTYVIO: Notice of Compliance 16576
Issued January 29, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16576
- Date
- January 29, 2015
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Selective immunosuppressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENTYVIO | 02436841 | Marketed |
Medicinal ingredients
- VEDOLIZUMAB 300 MG per VIAL